Effects of dihydropyridine calcium channel blockers, angiotensin- converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies

Journal of the American Society of Nephrology

Volumn 9, Issue 11, 1998, Pages 2096-2101

  Ruggenenti, Piero ^a,b,c   Perna, Annalisa ^a   Benini, Roberto ^a   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NIFEDIPINE; PLACEBO; RAMIPRIL; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME INHIBITION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0031758861     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1986
2. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HR, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
3. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL, for the Modification of Diet in Renal Disease (MDRD) Study Group: Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med 123: 754-762, 1995
4. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 51: 2-15, 1997
5. The GISEN Group: Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-1863, 1997
6. Ruggenenti P, Remuzzi G: The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes. Exp Nephrol 4[Suppl 1]: 53-60, 1996
7. Ruggenenti P, Remuzzi G: Angiotensin-converting enzyme inhibitor therapy for nondiabetic progressive renal disease. Curr Opin Nephrol Hypertens 6: 489-495, 1997
8. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
9. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541-549, 1990
10. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 39: 1267-1273, 1991
11. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 6: 36-43, 1993
12. Bohlen L, de Courten M, Weidmann P: Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 7: 84S-92S, 1994
13. Kasiske BL, Kalil RSN, Jennie Z, Liao M, Keane WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118: 129-138, 1993
14. Bakris GL, Mangrum A, Copley JB, Vicknair N, Sadler R: Calcium antagonists and progression of diabetic nephropathy in African-Americans. Hypertension 75: 744-750, 1997
15. Mathiensen ER, Hommel E, Giese J, Parving HH: Effect of captopril in postponing nephropathy in normotensive insulin dependent diabetics with microalbuminuria. Br Med J 303: 81-87, 1991
16. Mimran A, Insua A, Ribstein J, Monnier R, Bringer J, Mirouze J: Contrasting effects of captopril and nifedipine in normotensive patients with diabetic nephropathy. Br Med J 300: 904-907, 1990
17. DeMarie BK, Bakris GL: Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 113: 987-988, 1990
18. Bakris GL: Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 112: 707-708, 1990
19. Navar LG, Champion WJ, Thomas CE: Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin converting enzyme inhibition in dogs. Circ Res 58: 874-881, 1986
20. Anderson S: Renal hemodynamics of calcium antagonists in rats with reduced renal mass. Hypertension 17: 288-295, 1991
21. Carmines PK, Navar LG: Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am J Physiol 265: F1015-F1020, 1993
22. 2+] in renal arterioles. Am J Physiol 265: F677-F685, 1993
23. Griffin KA, Picken MM, Bidani AK: Deleterious effect of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 96: 793-800, 1995
24. Bakris GL, Smith A: Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Ann Intern Med 125: 201-204, 1996
25. Jyothirmayi GN, Reddi AS: Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats. Hypertension 21: 795-802, 1993
26. Gruppo Italiano Studi Epidemiologici in Nefrologia (G.I.S.E.N.): A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. J Nephrol 3: 193-202, 1991
27. Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, Daina E, Remuzzi G: Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6: 257-263, 1995
28. SAS Institute: SAS/STAT User's Guide, Version 6, 4th Ed. Vol. 1 and 2, Cary, NC: SAS Institute, Inc., 1989
29. Weidmann P, Schneider M, Bohlen L: Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis. Nephrol Dial Transplant 10[Suppl 9]: 39-45, 1995
30. Maki DD, Ma JZ, Louis TA, Kasiske BL: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 155: 1073-1080, 1995
31. Abbott K, Smith AC, Bakris GL: Effects of dihydropyridine calcium antagonists on albuminuria in diabetic subjects. J Clin Pharmacol 36: 274-279, 1996